Chronic Myeloproliferative Disorders Completed Phase 1 Trials for Pyroxamide (DB12847)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00042900Pyroxamide in Treating Patients With Advanced CancerTreatment